Merck gets Japanese nod for TEPMETKO(tepotinib) for non-small cell lung cancer Medical Dialogues Bureau28 March 2020 6:15 AM GMTTEPMETKO is the first regulatory approval globally for an oral MET inhibitor indicated for the treatment of advanced NSCLC harboring MET gene...
Pfizer gets EU nod to VIZIMPRO for treating lung cancer Farhat Nasim6 April 2019 4:10 AM GMTNew Delhi: Pfizer Inc. recently announced that the European Commission has approved VIZIMPRO (dacomitinib), a tyrosine kinase inhibitor (TKI), as...
Shilpa Medicare gets USFDA nod for Gemcitabine to treat types of cancer Farhat Nasim27 Feb 2019 4:00 AM GMTThe company has received US Food and Drug Administration (USFDA) approval for its Abbreviated New Drug Application (ANDA), Gemcitabine for injection US...
FDA approves Pfizer's Lorbrena treatment for certain lung cancer patients Medical Dialogues Bureau7 Nov 2018 4:10 AM GMTLorbrena, known chemically as lorlatinib, received an accelerated approval, Pfizer said. Its continued approval may depend on verification of clinical ...
Biocon launches colon cancer drug in India, priced Rs 24,000 Ruby Khatun Khatun24 Nov 2017 4:31 AM GMTBengaluru: Biocon Ltd has launched KRABEVA, a biosimilar Bevacizumab for the treatment of patients with metastatic colorectal cancer and other types...
CDSCO grants approval to AstraZeneca India for Breakthrough Therapy of lung cancer Ruby Khatun Khatun13 Nov 2017 12:09 PM GMTThrough a recent notification, Central Drugs Standard Control Organisation (CDSCO), Directorate General of Health Services, Ministry of Health and...
Roche cancer immunotherapy Tecentriq wins EU approval Ruby Khatun Khatun25 Sep 2017 4:47 AM GMTZURICH: Roche immunotherapy Tecentriq has won European Union approval for treating advanced lung and bladder cancer, the Swiss drugmaker said.The...
AstraZeneca rebuilds cancer drug hopes with new lung data Ruby Khatun Khatun12 Sep 2017 4:02 AM GMTMADRID: Two AstraZeneca drugs tackling lung cancer in different ways delivered encouraging results on Saturday, helping the British group offset...
